Skip to main content


Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Landscape of tumor suppressor long noncoding RNAs in breast cancer

Fig. 2

Extension validation of TSLNR expression in the pancancer cohort. a TSLNRs screened from the HMUCC and TCGA breast cancer cohorts were revalidated in the TCGA pancancer data, which included 33 cancer types and 12,839 patients. b TSLNRs that were expressed at significantly higher levels in the patients with early TNM stage (stage I & II) disease than in those with advanced stage (stage III & IV) disease in the pancancer data from TCGA. ****P < 0. 0001; *P < 0.05; NS: no significance

Back to article page